Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing methyl salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
1 |
Methyl salicylate liniment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methyl salicylate (substance) |
Inferred relationship |
Some |
|
Methyl salicylate ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methyl salicylate (substance) |
Inferred relationship |
Some |
|
Product containing iodine and methyl salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
1 |
Product containing menthol and methyl salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
1 |
Methyl salicylate powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methyl salicylate (substance) |
Inferred relationship |
Some |
|
Product containing diethyl phthalate and methyl salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
2 |
Menthol 30 microgram/mg and methyl salicylate 100 microgram/mg cutaneous patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methyl salicylate (substance) |
Inferred relationship |
Some |
|
Product containing camphor and menthol and methyl salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
2 |
Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methyl salicylate (substance) |
Inferred relationship |
Some |
|
Product containing methyl salicylate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
1 |
Camphor and menthol and methyl salicylate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
2 |
Product containing only diethyl phthalate and methyl salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
2 |
Product containing only iodine and methyl salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
1 |
Product containing only methyl salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
1 |
Product containing only menthol and methyl salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
1 |
Product containing only methyl salicylate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
1 |
Product containing only camphor and menthol and methyl salicylate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
2 |
Product containing only menthol and methyl salicylate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
1 |
Menthol 30 microgram/mg and methyl salicylate 100 microgram/mg cutaneous patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
1 |
Menthol 30 microgram/mg and methyl salicylate 100 microgram/mg cutaneous patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
1 |
Product containing camphor and menthol and methyl salicylate in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
2 |
Menthol- and methyl salicylate-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
1 |
Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
2 |
Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methyl salicylate (substance) |
Inferred relationship |
Some |
2 |